This blog post is in reference to my article in the May 2023 edition of the Lancet Psychiatry – Lithium Story: Eight Guidelines, Eight Recommendations . It is adapted from notes I sent to one of the editors when constructing the article
In a previous blog post , I looked at two examples of imprecise language in a Grandjean and Aubry paper about lithium pharmacokinetics (which I used in my May 2023 Lancet Psychiatry article). In this post, to show that the problem is not limited to a single paragraph in a single review paper, I have included a couple more examples of unclear messaging.
Example 3: “Typically, it has been considered that lithium concentrations should be maintained between 0.6 and 1.0 mmol/L”
This quote is from the Grandjean and Aubry paper, section 3.2: “Optimal Plasma Concentration Range: High versus low concentration”, first paragraph.
When the author mentions that “lithium concentrations should be maintained between 0.6 and 1.0 mmol/L” I think the values they are referring to are about a serum sample taken at 12 hours. However, I cannot be certain.
This particular example of lack of clarity is prominent in the literature .
All doubt could be removed with the short simple statement: “all serum concentration values mentioned in this section refer to 12-hour levels”. Even better, use the abbreviation introduced by Amdisen before each serum concentration mention (e.g. “a 12h-stSLi between 0.6 and 1.0 mmol/L”). It is such an easy fix.
Example 4: Steady-state pharmacokinetics of lithium carbonate in healthy subjects by R Hunter, Figure 1
The figure I am referencing in this example is the graph I have included in the appendix of my Lancet Psychiatry article. Here is the figure taken directly from a paper by Hunter :
The biggest problem with this graph is that the figure caption doesn’t say which line symbol corresponds to each subject. In fact, it isn’t even mentioned in the main text. It is possible to work it out from the values given in Table 2, but this makes it easy for mistakes to be made by the reader.
Further, the plot is misleading. I really don’t like the two scales used for the x-axis (I would have scaled the x-axis properly and then used an inset graph, top right, to show the 0 – 6 hour values in detail). The improper scaling makes it look like each subject’s pharmacokinetic curve after peak concentration follows a one-compartment model (instead of the two-compartment model of lithium ).
I have made a very quick plot below of the subject represented by the filled circles with proper scaling for reference.
References
{8240280:G4KERCFZ};{8240280:QXBDH2EN},{8240280:5ADQINJC},{8240280:PZGWUBCY},{8240280:R4L2DWBP},{8240280:9EZW6IND};{8240280:PP279J38};{8240280:UQT6WQ9K};{8240280:AJ7FWFI9}
vancouver
0
784
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-fe89e27ac9ab1e272078885ed079c0e1%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22AJ7FWFI9%22%2C%22library%22%3A%7B%22id%22%3A8240280%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Bauer%22%2C%22parsedDate%22%3A%222008%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EBauer%20LA.%20Chapter%2017.%20Lithium.%20In%3A%20Bauer%20LA%2C%20editor.%20Applied%20Clinical%20Pharmacokinetics%2C%202e%20%5BInternet%5D.%20New%20York%2C%20NY%3A%20The%20McGraw-Hill%20Companies%3B%202008%20%5Bcited%202023%20Feb%207%5D.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Faccesspharmacy.mhmedical.com%5C%2Fcontent.aspx%3Faid%3D3518187%27%3Ehttps%3A%5C%2F%5C%2Faccesspharmacy.mhmedical.com%5C%2Fcontent.aspx%3Faid%3D3518187%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22bookSection%22%2C%22title%22%3A%22Chapter%2017.%20Lithium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Larry%20A.%22%2C%22lastName%22%3A%22Bauer%22%7D%2C%7B%22creatorType%22%3A%22editor%22%2C%22firstName%22%3A%22Larry%20A.%22%2C%22lastName%22%3A%22Bauer%22%7D%5D%2C%22abstractNote%22%3A%22Lithium%20%20is%20%20an%20%20alkali%20%20metal%20%20that%20%20is%20%20administered%20%20as%20%20a%20%20monovalent%20%20cation%20%20%28Li%2B%29%20%20for%20%20the%20%20treatment%20%20of%20%20bipolar%20%20disorder.%20%20In%20%20the%20%20United%20%20States%2C%20%20orally%20%20administered%20%20carbonate%20%20and%20%20citrate%20%20salts%20%20of%20%20lithium%20%20are%20%20available.%20%20While%20%20lithium%20%20is%20%20still%20%20used%20%20as%20%20a%20%20primary%20%20treatment%20%20for%20%20bipolar%20%20disorders%2C%20%20valproic%20%20acid%2C%20%20lamotrigine%2C%20%20or%20%20carbamazepine%20%20may%20%20be%20%20used%20%20for%20%20some%20%20subsets%20%20of%20%20the%20%20disease.1%20%20Although%20%20this%20%20drug%20%20has%20%20been%20%20used%20%20in%20%20psychiatric%20%20medicine%20%20since%20%20the%20%201940s%2C%20%20the%20%20mechanism%20%20of%20%20action%20%20of%20%20lithium%20%20is%20%20largely%20%20unknown.%20%20Among%20%20the%20%20current%20%20theories%20%20are%20%20competition%20%20with%20%20other%20%20cations%20%20at%20%20receptor%20%20and%20%20tissue%20%20sites%2C%20%20dopamine-receptor%20%20supersensitivity%20%20blockage%2C%20%20decreased%20%20stimulation%20%20of%20%20%5Cu03b2-receptor%20%20induced%20%20adenylate%20%20cyclase%2C%20%20and%20%20enhanced%20%20sensitivity%20%20to%20%20serotonin%20%20%285-HT%29%2C%20%20acetylcholine%2C%20%20and%20%20%5Cu03b3-aminobutyric%20%20acid%20%20%28GABA%29.1%2C2%22%2C%22bookTitle%22%3A%22Applied%20Clinical%20Pharmacokinetics%2C%202e%22%2C%22date%22%3A%222008%22%2C%22language%22%3A%22%22%2C%22ISBN%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Faccesspharmacy.mhmedical.com%5C%2Fcontent.aspx%3Faid%3D3518187%22%2C%22collections%22%3A%5B%2229LUPNNK%22%2C%22SARIPJM9%22%5D%2C%22dateModified%22%3A%222023-09-02T10%3A50%3A39Z%22%7D%7D%2C%7B%22key%22%3A%22PP279J38%22%2C%22library%22%3A%7B%22id%22%3A8240280%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Amdisen%22%2C%22parsedDate%22%3A%221977-04-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAmdisen%20A.%20Serum%20Level%20Monitoring%20and%20Clinical%20Pharmacokinetics%20of%20Lithium.%20Clin%20Pharmacokinet%20%5BInternet%5D.%201977%20Apr%201%20%5Bcited%202023%20Feb%207%5D%3B2%282%29%3A73%26%23x2013%3B92.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2165%5C%2F00003088-197702020-00001%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2165%5C%2F00003088-197702020-00001%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Serum%20Level%20Monitoring%20and%20Clinical%20Pharmacokinetics%20of%20Lithium%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Amdi%22%2C%22lastName%22%3A%22Amdisen%22%7D%5D%2C%22abstractNote%22%3A%22Short-term%20antimanic%20therapy%20with%20lithium%20and%20relapse-repressive%2C%20so-called%20%5Cu2018prophylactic%5Cu2019%20long-term%20therapy%20with%20lithium%2C%20may%20present%20clinical%20problems%20which%20demand%20an%20understanding%20of%20two%20cardinal%20properties%20of%20this%20form%20of%20therapy%20%5Cu2014%20the%20need%20to%20individualise%20the%20dose%20and%20the%20recognition%20that%20successful%20therapy%20involves%20the%20use%20of%20near-toxic%20dosage.%20Therefore%2C%20treatment%20must%20be%20constantly%20supervised%2C%20not%20only%20by%20the%20physician%20but%20also%20primarily%20by%20the%20patient%20himself%2C%20especially%20to%20avoid%20the%20ever-present%20risk%20of%20intoxication.%22%2C%22date%22%3A%221977-04-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.2165%5C%2F00003088-197702020-00001%22%2C%22ISSN%22%3A%221179-1926%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2165%5C%2F00003088-197702020-00001%22%2C%22collections%22%3A%5B%2229LUPNNK%22%2C%22Q4ZEDHYX%22%2C%22BTQKKR2F%22%5D%2C%22dateModified%22%3A%222023-02-07T12%3A58%3A00Z%22%7D%7D%2C%7B%22key%22%3A%229EZW6IND%22%2C%22library%22%3A%7B%22id%22%3A8240280%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Parfitt%20et%20al.%22%2C%22parsedDate%22%3A%222021-01-12%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EParfitt%20C%2C%20Duff%20CJ%2C%20Scargill%20J%2C%20Green%20L%2C%20Holland%20D%2C%20Heald%20AH%2C%20et%20al.%20Serum%20lithium%20test%20requesting%20across%20three%20UK%20regions%3A%20an%20evaluation%20of%20adherence%20to%20monitoring%20guidelines.%20BMC%20Psychiatry%20%5BInternet%5D.%202021%20Jan%2012%20%5Bcited%202022%20Dec%2026%5D%3B21%281%29%3A32.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12888-020-03023-y%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12888-020-03023-y%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Serum%20lithium%20test%20requesting%20across%20three%20UK%20regions%3A%20an%20evaluation%20of%20adherence%20to%20monitoring%20guidelines%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ceri%22%2C%22lastName%22%3A%22Parfitt%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%20J.%22%2C%22lastName%22%3A%22Duff%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Scargill%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lewis%22%2C%22lastName%22%3A%22Green%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%22%2C%22lastName%22%3A%22Holland%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Adrian%20H.%22%2C%22lastName%22%3A%22Heald%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%20A.%22%2C%22lastName%22%3A%22Fryer%22%7D%5D%2C%22abstractNote%22%3A%22Bipolar%20disorder%20is%20the%20fourth%20most%20common%20mental%20health%20condition%2C%20affecting%20~%5Cu20091%25%20of%20UK%20adults.%20Lithium%20is%20an%20effective%20treatment%20for%20prevention%20of%20relapse%20and%20hospital%20admission%2C%20and%20is%20widely%20recommended%20as%20a%20first-line%20treatment.%20We%20previously%20showed%20in%20other%20areas%20that%20laboratory%20testing%20patterns%20are%20variable%20with%20sub-optimal%20conformity%20to%20guidance.%20We%20therefore%20examined%20lithium%20results%20and%20requesting%20patterns%20relative%20to%20monitoring%20recommendations.%22%2C%22date%22%3A%222021-01-12%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1186%5C%2Fs12888-020-03023-y%22%2C%22ISSN%22%3A%221471-244X%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1186%5C%2Fs12888-020-03023-y%22%2C%22collections%22%3A%5B%2229LUPNNK%22%2C%22Q4ZEDHYX%22%2C%22SARIPJM9%22%5D%2C%22dateModified%22%3A%222022-12-26T13%3A01%3A47Z%22%7D%7D%2C%7B%22key%22%3A%225ADQINJC%22%2C%22library%22%3A%7B%22id%22%3A8240280%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Malhi%20et%20al.%22%2C%22parsedDate%22%3A%222017-08-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMalhi%20GS%2C%20Gessler%20D%2C%20Outhred%20T.%20The%20use%20of%20lithium%20for%20the%20treatment%20of%20bipolar%20disorder%3A%20Recommendations%20from%20clinical%20practice%20guidelines.%20Journal%20of%20Affective%20Disorders%20%5BInternet%5D.%202017%20Aug%201%20%5Bcited%202022%20Dec%2023%5D%3B217%3A266%26%23x2013%3B80.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0165032716323564%27%3Ehttps%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0165032716323564%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20use%20of%20lithium%20for%20the%20treatment%20of%20bipolar%20disorder%3A%20Recommendations%20from%20clinical%20practice%20guidelines%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gin%20S.%22%2C%22lastName%22%3A%22Malhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Danielle%22%2C%22lastName%22%3A%22Gessler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tim%22%2C%22lastName%22%3A%22Outhred%22%7D%5D%2C%22abstractNote%22%3A%22Background%5CnLithium%20is%20an%20effective%20mood%20stabilizer%20that%20is%20used%20principally%20for%20the%20management%20of%20bipolar%20disorder%20%28BD%29.%20Its%20administration%20is%20complex%20and%20often%20requires%20sophisticated%20management%20and%20assiduous%20monitoring.%20When%20considering%20the%20use%20of%20lithium%20therapy%20for%20bipolar%20disorder%2C%20clinicians%20are%20advised%20to%20refer%20to%20recommendations%20outlined%20in%20clinical%20practice%20guidelines%20%28CPGs%29%3B%20but%20because%20of%20varying%20emphases%20placed%20by%20different%20international%20CPGs%2C%20recommendations%20addressing%20the%20practical%20use%20of%20lithium%20lack%20consistency.%5CnMethod%5CnIn%20order%20to%20inform%20clinicians%20of%20optimal%20lithium%20therapy%20for%20bipolar%20disorder%2C%20we%20compared%20and%20synthesized%20recommendations%20for%20the%20treatment%20of%20bipolar%20disorder%20made%20by%20recognized%20CPGs%20internationally.%20We%20conducted%20a%20search%20of%20the%20literature%20and%20extracted%20guidance%20across%20multiple%20clinical%20issues%2C%20including%20clinical%20indications%2C%20disorder%20subtypes%2C%20additional%20uses%2C%20special%20populations%2C%20practical%20aspects%2C%20and%20side%20effects.%5CnResults%5CnCollectively%2C%20CPGs%20consider%20lithium%20most%20robustly%20as%20a%20first-line%20intervention%20for%20maintenance%20treatment%20of%20bipolar%20disorder%20and%20strongly%20for%20the%20treatment%20of%20mania%2C%20with%20relatively%20modest%20support%20for%20the%20management%20of%20acute%20bipolar%20depression.%20Additionally%2C%20there%20is%20consensus%20across%20the%20CPGs%20that%20lithium%20tangibly%20reduces%20the%20risk%20of%20suicide.%20Generally%2C%20CPGs%20provide%20guidance%20on%20the%20many%20facets%20of%20initiating%20and%20maintaining%20patients%20on%20lithium%20therapy%2C%20but%20individually%20the%20CPGs%20varied%20in%20terms%20of%20depth%20and%20practical%20guidance%20they%20provide%20across%20these%20areas.%20However%2C%20consensus%20was%20established%20across%20many%20key%20areas%20of%20practice%20such%20as%20the%20ideal%20lithium%20plasma%20concentration%20for%20maintenance%20and%20monitoring%20%280.6%5Cu20130.8mmol%5C%2FL%29%2C%20along%20with%20the%20need%20for%20regular%20monitoring%20of%20renal%20and%20endocrine%20function.%20However%2C%20with%20more%20complex%20aspects%20%28e.g.%2C%20atypical%20presentations%29%20and%20in%20special%20populations%20%28e.g.%2C%20youth%3B%20pregnancy%20and%20post-partum%3B%20older%20adults%29%2C%20guidance%20varied%20considerably%20and%20clear%20consensus%20recommendations%20were%20more%20difficult%20to%20achieve.%20In%20younger%20adults%20desirable%20plasma%20lithium%20levels%20of%200.6%5Cu20130.8mmol%5C%2FL%20can%20perhaps%20be%20achieved%20with%20comparatively%20lower%20doses%20and%20in%20the%20very%20elderly%20it%20may%20be%20prudent%20to%20target%20lower%20plasma%20levels%20in%20the%20first%20instance.%20These%20are%20important%20practical%20points%20for%20consideration%20that%2C%20along%20with%20many%20others%20offered%20throughout%20the%20article%2C%20should%20assist%20clinicians%20in%20dissecting%20the%20more%20complex%20aspects%20of%20management%20with%20greater%20precision.%5CnLimitations%5CnThis%20review%20was%20limited%20to%20CPGs%20written%20in%20English.%20CPGs%20are%20themselves%20limited%20by%20reliance%20on%20evidence%20that%20often%20has%20little%20resemblance%20to%20real-world%20presentations.%20An%20important%20area%20that%20is%20not%20sufficiently%20addressed%20in%20the%20CPGs%20is%20clear%20guidance%20on%20the%20cessation%20of%20lithium%20therapy.%5CnConclusions%5CnFurther%20research%20is%20needed%20on%20many%20aspects%20of%20lithium%20therapy%20and%20this%20alongside%20existing%20knowledge%20needs%20to%20be%20used%20more%20consistently%20to%20inform%20CPGs%2C%20which%20should%20also%20incorporate%20empirical%20evidence%20and%20clinical%20experience.%20The%20recommendations%20in%20this%20paper%20provide%20a%20useful%20synthesis%20of%20guidance%20available%20currently.%22%2C%22date%22%3A%222017-08-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jad.2017.03.052%22%2C%22ISSN%22%3A%220165-0327%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS0165032716323564%22%2C%22collections%22%3A%5B%2229LUPNNK%22%2C%22TR3FFNMG%22%2C%22Q4ZEDHYX%22%2C%22SARIPJM9%22%5D%2C%22dateModified%22%3A%222022-12-23T17%3A07%3A10Z%22%7D%7D%2C%7B%22key%22%3A%22PZGWUBCY%22%2C%22library%22%3A%7B%22id%22%3A8240280%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Vestergaard%20and%20Licht%22%2C%22parsedDate%22%3A%222001-01-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EVestergaard%20P%2C%20Licht%20RW.%2050%20Years%20with%20Lithium%20Treatment%20in%20Affective%20Disorders%3A%20Present%20Problems%20and%20Priorities.%20The%20World%20Journal%20of%20Biological%20Psychiatry%20%5BInternet%5D.%202001%20Jan%201%20%5Bcited%202022%20Nov%2028%5D%3B2%281%29%3A18%26%23x2013%3B26.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3109%5C%2F15622970109039980%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3109%5C%2F15622970109039980%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%2250%20Years%20with%20Lithium%20Treatment%20in%20Affective%20Disorders%3A%20Present%20Problems%20and%20Priorities%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Per%22%2C%22lastName%22%3A%22Vestergaard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rasmus%20W.%22%2C%22lastName%22%3A%22Licht%22%7D%5D%2C%22abstractNote%22%3A%22Lithium%20has%20been%20used%20as%20a%20treatment%20for%20various%20psychiatric-and%20somatic-illnesses%20for%20more%20than%2050%20years.%20Today%20the%20main%20use%20of%20lithium%20is%20for%20the%20prevention%20of%20episode%20recurrences%20in%20bipolar%20disorder.%20The%20main%20emphasis%20of%20this%20review%20will%20be%20on%20the%20efficacy%20and%20effectiveness%20of%20lithium%20prophylaxis%20in%20bipolar%20disorder%20but%20the%20review%20will%20also%20discuss%20other%20indications%20for%20lithium%20treatment%2C%20the%20historical%20development%2C%20pharmacokinetic%20and-dynamic%20issues%2C%20unwanted%20effects%20of%20lithium%20and%20the%20organisation%20of%20treatment%20services.%20Finally%2C%20although%20not%20the%20main%20purpose%20of%20this%20review%2C%20a%20short%20description%20of%20alternative%20mood%20stabilizing%20drugs%20will%20also%20be%20presented.%22%2C%22date%22%3A%222001-01-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.3109%5C%2F15622970109039980%22%2C%22ISSN%22%3A%221562-2975%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3109%5C%2F15622970109039980%22%2C%22collections%22%3A%5B%2229LUPNNK%22%2C%22Q4ZEDHYX%22%2C%22KGVJ9D72%22%2C%22SARIPJM9%22%5D%2C%22dateModified%22%3A%222022-11-28T12%3A58%3A14Z%22%7D%7D%2C%7B%22key%22%3A%22R4L2DWBP%22%2C%22library%22%3A%7B%22id%22%3A8240280%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Aronson%20and%20Reynolds%22%2C%22parsedDate%22%3A%221992-11-21%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EAronson%20JK%2C%20Reynolds%20DJ.%20ABC%20of%20monitoring%20drug%20therapy.%20Lithium.%20BMJ%20%5BInternet%5D.%201992%20Nov%2021%20%5Bcited%202022%20Nov%2025%5D%3B305%286864%29%3A1273%26%23x2013%3B4.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fwww.bmj.com%5C%2Fcontent%5C%2F305%5C%2F6864%5C%2F1273%27%3Ehttps%3A%5C%2F%5C%2Fwww.bmj.com%5C%2Fcontent%5C%2F305%5C%2F6864%5C%2F1273%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22ABC%20of%20monitoring%20drug%20therapy.%20Lithium.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22J.%20K.%22%2C%22lastName%22%3A%22Aronson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%20J.%22%2C%22lastName%22%3A%22Reynolds%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%221992%5C%2F11%5C%2F21%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmj.305.6864.1273%22%2C%22ISSN%22%3A%220959-8138%2C%201468-5833%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.bmj.com%5C%2Fcontent%5C%2F305%5C%2F6864%5C%2F1273%22%2C%22collections%22%3A%5B%2229LUPNNK%22%2C%22SARIPJM9%22%5D%2C%22dateModified%22%3A%222022-11-25T13%3A55%3A55Z%22%7D%7D%2C%7B%22key%22%3A%22UQT6WQ9K%22%2C%22library%22%3A%7B%22id%22%3A8240280%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hunter%22%2C%22parsedDate%22%3A%221988%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EHunter%20R.%20Steady-state%20pharmacokinetics%20of%20lithium%20carbonate%20in%20healthy%20subjects.%20British%20Journal%20of%20Clinical%20Pharmacology%20%5BInternet%5D.%201988%20%5Bcited%202022%20Nov%2025%5D%3B25%283%29%3A375%26%23x2013%3B80.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1111%5C%2Fj.1365-2125.1988.tb03316.x%27%3Ehttps%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1111%5C%2Fj.1365-2125.1988.tb03316.x%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Steady-state%20pharmacokinetics%20of%20lithium%20carbonate%20in%20healthy%20subjects.%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R%22%2C%22lastName%22%3A%22Hunter%22%7D%5D%2C%22abstractNote%22%3A%221.%20The%20pharmacokinetics%20of%20lithium%20in%20six%20healthy%20volunteers%20stabilised%20on%20lithium%20were%20investigated%20and%20appropriate%20pharmacokinetic%20parameters%20calculated.%202.%20The%20results%20illustrate%20important%20differences%20in%20single%20and%20multiple%20dose%20lithium%20pharmacokinetics%3B%20the%20implications%20for%20minimising%20lithium-induced%20renal%20damage%20are%20discussed.%22%2C%22date%22%3A%221988%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1111%5C%2Fj.1365-2125.1988.tb03316.x%22%2C%22ISSN%22%3A%221365-2125%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fonlinelibrary.wiley.com%5C%2Fdoi%5C%2Fabs%5C%2F10.1111%5C%2Fj.1365-2125.1988.tb03316.x%22%2C%22collections%22%3A%5B%2229LUPNNK%22%2C%22NW9MAAWI%22%2C%22Q4ZEDHYX%22%5D%2C%22dateModified%22%3A%222022-11-25T13%3A55%3A17Z%22%7D%7D%2C%7B%22key%22%3A%22G4KERCFZ%22%2C%22library%22%3A%7B%22id%22%3A8240280%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Grandjean%20and%20Aubry%22%2C%22parsedDate%22%3A%222009%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EGrandjean%20EM%2C%20Aubry%20JM.%20Lithium%3A%20updated%20human%20knowledge%20using%20an%20evidence-based%20approach.%20Part%20II%3A%20Clinical%20pharmacology%20and%20therapeutic%20monitoring.%20CNS%20Drugs.%202009%3B23%284%29%3A331%26%23x2013%3B49.%3C%5C%2Fdiv%3E%5Cn%20%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Lithium%3A%20updated%20human%20knowledge%20using%20an%20evidence-based%20approach.%20Part%20II%3A%20Clinical%20pharmacology%20and%20therapeutic%20monitoring%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Etienne%20Marc%22%2C%22lastName%22%3A%22Grandjean%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean-Michel%22%2C%22lastName%22%3A%22Aubry%22%7D%5D%2C%22abstractNote%22%3A%22After%20a%20single%20dose%2C%20lithium%2C%20usually%20given%20as%20carbonate%2C%20reaches%20a%20peak%20plasma%20concentration%20at%201.0-2.0%20hours%20for%20standard-release%20dosage%20forms%2C%20and%204-5%20hours%20for%20sustained-release%20forms.%20Its%20bioavailability%20is%2080-100%25%2C%20its%20total%20clearance%2010-40%20mL%5C%2Fmin%20and%20its%20elimination%20half-life%20is%2018-36%20hours.%20Use%20of%20the%20sustained-release%20formulation%20results%20in%2030-50%25%20reductions%20in%20peak%20plasma%20concentrations%20without%20major%20changes%20in%20the%20area%20under%20the%20plasma%20concentration%20curve.%20Lithium%20distribution%20to%20the%20brain%2C%20evaluated%20using%207Li%20magnetic%20resonance%20spectroscopy%2C%20showed%20brain%20concentrations%20to%20be%20approximately%20half%20those%20in%20serum%2C%20occasionally%20increasing%20to%2075-80%25.%20Brain%20concentrations%20were%20weakly%20correlated%20with%20serum%20concentrations.%20Lithium%20is%20almost%20exclusively%20excreted%20via%20the%20kidney%20as%20a%20free%20ion%20and%20lithium%20clearance%20is%20considered%20to%20decrease%20with%20aging.%20No%20gender-%20or%20race-related%20differences%20in%20kinetics%20have%20been%20demonstrated.%20Renal%20insufficiency%20is%20associated%20with%20a%20considerable%20reduction%20in%20renal%20clearance%20of%20lithium%20and%20is%20considered%20a%20contraindication%20to%20its%20use%2C%20especially%20if%20a%20sodium-poor%20diet%20is%20required.%20During%20the%20last%20months%20of%20pregnancy%2C%20lithium%20clearance%20increases%20by%2030-50%25%20as%20a%20result%20of%20an%20increase%20in%20glomerular%20filtration%20rate.%20Lithium%20also%20passes%20freely%20from%20maternal%20plasma%20into%20breast%20milk.%20Numerous%20kinetic%20interactions%20have%20been%20described%20for%20lithium%2C%20usually%20involving%20a%20decrease%20in%20the%20drug%27s%20clearance%20and%20therefore%20increasing%20its%20potential%20toxicity.%20Clinical%20pharmacology%20studies%20performed%20in%20healthy%20volunteers%20have%20investigated%20a%20possible%20effect%20of%20lithium%20on%20cognitive%20functions.%20Most%20of%20these%20studies%20reported%20a%20slight%2C%20negative%20effect%20on%20vigilance%2C%20alertness%2C%20learning%20and%20short-term%20memory%20after%20long-term%20administration%20only.%20Because%20of%20the%20narrow%20therapeutic%20range%20of%20lithium%2C%20therapeutic%20monitoring%20is%20the%20basis%20for%20optimal%20use%20and%20administration%20of%20this%20drug.%20Lithium%20dosages%20should%20be%20adjusted%20on%20the%20basis%20of%20the%20serum%20concentration%20drawn%20%28optimally%29%2012%20hours%20after%20the%20last%20dose.%20In%20patients%20receiving%20once-daily%20administration%2C%20the%20serum%20concentration%20at%2024%20hours%20should%20serve%20as%20the%20control%20value.%20The%20efficacy%20of%20lithium%20is%20clearly%20dose-dependent%20and%20reliably%20correlates%20with%20serum%20concentrations.%20It%20is%20now%20generally%20accepted%20that%20concentrations%20should%20be%20maintained%20between%200.6%20and%200.8%20mmol%5C%2FL%2C%20although%20some%20authors%20still%20favour%200.8-1.2%20mmol%5C%2FL.%20With%20sustained-release%20preparations%2C%20and%20because%20of%20the%20later%20peak%20of%20serum%20lithium%20concentration%2C%20it%20is%20advised%20to%20keep%20serum%20concentrations%20within%20the%20upper%20range%20%280.8-1%20mmol%5C%2FL%29%2C%20rather%20than%200.6-0.8%20mmol%5C%2FL%20for%20standard%20formulations.%20It%20is%20controversial%20whether%20a%20reduced%20concentration%20is%20required%20in%20elderly%20people.%20The%20usual%20maintenance%20daily%20dose%20is%2025-35%20mmol%20%28lithium%20carbonate%20925-1300%20mg%29%20for%20patients%20aged%20%3C40%20years%3B%2020-25%20mmol%20%28740-925%20mg%29%20for%20those%20aged%2040-60%20years%3B%20and%2015-20%20mmol%20%28550-740%20mg%29%20for%20patients%20aged%20%3E60%20years.%20The%20initial%20recommended%20dose%20is%20usually%2012-24%20mmol%20%28450-900%20mg%29%20per%20day%2C%20depending%20on%20age%20and%20bodyweight.%20The%20classical%20administration%20schedule%20is%20two%20or%20three%20times%20daily%2C%20although%20there%20is%20no%20strong%20evidence%20in%20favour%20of%20a%20three-times-daily%20schedule%2C%20and%20compliance%20with%20the%20midday%20dose%20is%20questionable.%20With%20a%20modern%20sustained-release%20preparation%2C%20the%20twice-daily%20schedule%20is%20well%20established%2C%20although%20one%20single%20evening%20dose%20is%20being%20recommended%20by%20a%20number%20of%20expert%20panels.%22%2C%22date%22%3A%222009%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.2165%5C%2F00023210-200923040-00005%22%2C%22ISSN%22%3A%221172-7047%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%2229LUPNNK%22%2C%22SARIPJM9%22%5D%2C%22dateModified%22%3A%222022-11-25T13%3A54%3A31Z%22%7D%7D%2C%7B%22key%22%3A%22QXBDH2EN%22%2C%22library%22%3A%7B%22id%22%3A8240280%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Malhi%20and%20Tanious%22%2C%22parsedDate%22%3A%222011-04-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%201.35%3B%20%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%20style%3D%5C%22clear%3A%20left%3B%20%5C%22%3E%5Cn%20%20%20%20%3Cdiv%20class%3D%5C%22csl-left-margin%5C%22%20style%3D%5C%22float%3A%20left%3B%20padding-right%3A%200.5em%3B%20text-align%3A%20right%3B%20width%3A%201em%3B%5C%22%3E1.%3C%5C%2Fdiv%3E%3Cdiv%20class%3D%5C%22csl-right-inline%5C%22%20style%3D%5C%22margin%3A%200%20.4em%200%201.5em%3B%5C%22%3EMalhi%20GS%2C%20Tanious%20M.%20Optimal%20Frequency%20of%20Lithium%20Administration%20in%20the%20Treatment%20of%20Bipolar%20Disorder.%20CNS%20Drugs%20%5BInternet%5D.%202011%20Apr%201%20%5Bcited%202022%20Nov%2025%5D%3B25%284%29%3A289%26%23x2013%3B98.%20Available%20from%3A%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2165%5C%2F11586970-000000000-00000%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2165%5C%2F11586970-000000000-00000%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%20%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Optimal%20Frequency%20of%20Lithium%20Administration%20in%20the%20Treatment%20of%20Bipolar%20Disorder%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gin%20S.%22%2C%22lastName%22%3A%22Malhi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michelle%22%2C%22lastName%22%3A%22Tanious%22%7D%5D%2C%22abstractNote%22%3A%22Bipolar%20disorder%20is%20a%20recurrent%20chronic%20illness%20distinguished%20by%20periods%20of%20mania%20and%20depression.%20Lithium%20has%20been%20used%20for%20about%2060%20years%20as%20a%20%5Cu2018mood%20stabilizer%5Cu2019%20for%20bipolar%20disorder%20with%20proven%20efficacy%20in%20preventing%20relapse%20of%20both%20mania%20and%20depression.%20Despite%20its%20long%20history%20and%20ongoing%20use%20in%20current%20management%20of%20bipolar%20disorder%2C%20the%20optimal%20dosing%20of%20lithium%20is%20still%20the%20subject%20of%20ongoing%20debate.%20This%20article%20aims%20to%20evaluate%20different%20dosing%20schedules%2C%20in%20the%20light%20of%20the%20unique%20pharmacokinetic%20and%20pharmacodynamic%20properties%20of%20lithium%2C%20as%20well%20as%20its%20adverse-effect%20and%20toxicity%20profiles.%20This%20is%20all%20the%20more%20important%20given%20the%20narrow%20therapeutic%20index%20of%20lithium.%20Current%20recommendations%20mostly%20advocate%20that%20lithium%20be%20administered%20in%20multiple%20daily%20doses.%20However%2C%20single%20daily%20or%20alternate%20daily%20schedules%20may%20be%20viable%20options%20for%20administration.%20Multiple%20daily%20schedules%20are%20thought%20to%20be%20advantageous%20in%20maintaining%20more%20constant%20plasma%20lithium%20concentrations%20than%20single%20daily%20regimens%2C%20which%20are%20associated%20with%20significant%20fluctuations%20throughout%20the%20day.%20When%20comparing%20these%20two%20schedules%20with%20respect%20to%20plasma%20lithium%20concentrations%2C%20adverse-effect%20profiles%20and%20recurrence%20of%20symptoms%2C%20there%20are%20no%20significant%20differences%20between%20the%20two%20regimens.%20In%20fact%2C%20a%20single%20daily%20regimen%20may%20have%20added%20advantages%20in%20reducing%20the%20risk%20of%20long-term%20renal%20damage%20and%20increasing%20compliance.%20The%20evidence%20for%20alternate%20daily%20dosing%20is%20somewhat%20varied%20with%20regard%20to%20symptom%20recurrence%3B%20however%2C%20this%20schedule%20has%20been%20shown%20to%20be%20associated%20with%20decreased%20adverse%20effects%2C%20and%20further%20research%20into%20this%20issue%20is%20therefore%20warranted.%20Presently%2C%20therefore%2C%20clinicians%20should%20consider%20single%20daily%20administration%20of%20lithium%20to%20potentially%20minimize%20adverse%20effects%20and%20enhance%20compliance.%22%2C%22date%22%3A%222011-04-01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.2165%5C%2F11586970-000000000-00000%22%2C%22ISSN%22%3A%221179-1934%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2165%5C%2F11586970-000000000-00000%22%2C%22collections%22%3A%5B%2229LUPNNK%22%2C%22KGVJ9D72%22%5D%2C%22dateModified%22%3A%222022-11-25T13%3A31%3A49Z%22%7D%7D%5D%7D
1.
Parfitt C, Duff CJ, Scargill J, Green L, Holland D, Heald AH, et al. Serum lithium test requesting across three UK regions: an evaluation of adherence to monitoring guidelines. BMC Psychiatry [Internet]. 2021 Jan 12 [cited 2022 Dec 26];21(1):32. Available from:
https://doi.org/10.1186/s12888-020-03023-y
1.
Vestergaard P, Licht RW. 50 Years with Lithium Treatment in Affective Disorders: Present Problems and Priorities. The World Journal of Biological Psychiatry [Internet]. 2001 Jan 1 [cited 2022 Nov 28];2(1):18–26. Available from:
https://doi.org/10.3109/15622970109039980
1.
Grandjean EM, Aubry JM. Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring. CNS Drugs. 2009;23(4):331–49.